Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
Atrial Fibrillation (AF) is the most common arrhythmia and affects about 2% of the population in Europe. This prevalence is going to increase. One in four people who are 40 years old or over are likely to develop AF, and almost all of them are at high risk of developing stroke. Oral anticoagulants can prevent the majority of ischemic strokes in AF patients.
The ESC’s Cardiovascular Round Table brought together an expert group of academics, clinical practice guideline writers, patient, regulatory and industry representatives, all of whom are intricately involved in the development of NOACs in phase III trials, to discuss unanswered questions.
Paulus Kirchhof, FESC, explains why early detection and diagnosis of AF is a critical issue for all health stakeholders
Access slides and webcasts from a selection of presentations made during the CRT workshop.
A summary of the main points from the workshop co-chairs, Prof. Paulus Kirchhof, FESC and Dr. Stefan Schroeder.
Our Mission: To Reduce the Burden of Cardiovascular Disease
© 2019 European Society of Cardiology. All rights reserved